Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Clin. transl. oncol. (Print) ; 23(10): 2181-2190, oct. 2021.
Article in English | IBECS | ID: ibc-223389

ABSTRACT

Purpose Chimeric antigen receptor (CAR) T cell development for B cell malignancies treatment has triggered a paradigm shift in oncology. The development of anti-CD19 CAR T cells relies primarily on a panel of cell line-derived xenograft models, including Raji cells; however, the behavior of this model is under debate. We attempted to characterize this lymphoma model and propose outcome measures for CAR T cell studies Methods Raji cell line was inoculated into NOG mice via intra-venous (IV), intra-peritoneal (IP), and subcutaneous (SC) routes with different inoculum sizes, and consequent clinical and histopathological outcomes were assessed. Results Inoculum sizes of 105–106 resulted in a complete take rate. The mice with IV and SC-inoculated Raji cells presented the shortest and longest survival among lymphoma-bearing mice, respectively (P < 0.01). The IP group had the highest number of both infiltrated organs (P < 0.05; compared to SC) and involvement of lymphatic sites (P < 0.05; compared to IV). The number of lymphoma lesions on the liver was higher in the IV compared to IP (P < 0.001) and SC (P < 0.05). Conclusion We demonstrate that the Raji cell line inoculation route could determine the xenograft model system behavior in terms of survival, tumor burden, and dissemination pattern and gives the model the specific features suitable for testing the specific hypothesis in CAR T cell therapy. We also conclude outcome measures for CAR T cell studies that do not require imaging techniques (AU)


Subject(s)
Animals , Male , Female , Mice , Antigens, CD19/immunology , Immunotherapy, Adoptive/methods , Lymphoma, Non-Hodgkin/therapy , Receptors, Chimeric Antigen , Xenograft Model Antitumor Assays , Cell Line, Tumor , Disease Models, Animal , Lymphoma, Non-Hodgkin/mortality , Lymphoma, Non-Hodgkin/pathology , Mice, Inbred NOD , Neoplasm Invasiveness , Random Allocation , T-Lymphocytes/immunology , Body Weight
2.
Clin Transl Oncol ; 23(10): 2181-2190, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33942221

ABSTRACT

PURPOSE: Chimeric antigen receptor (CAR) T cell development for B cell malignancies treatment has triggered a paradigm shift in oncology. The development of anti-CD19 CAR T cells relies primarily on a panel of cell line-derived xenograft models, including Raji cells; however, the behavior of this model is under debate. We attempted to characterize this lymphoma model and propose outcome measures for CAR T cell studies METHODS: Raji cell line was inoculated into NOG mice via intra-venous (IV), intra-peritoneal (IP), and subcutaneous (SC) routes with different inoculum sizes, and consequent clinical and histopathological outcomes were assessed. RESULTS: Inoculum sizes of 105-106 resulted in a complete take rate. The mice with IV and SC-inoculated Raji cells presented the shortest and longest survival among lymphoma-bearing mice, respectively (P < 0.01). The IP group had the highest number of both infiltrated organs (P < 0.05; compared to SC) and involvement of lymphatic sites (P < 0.05; compared to IV). The number of lymphoma lesions on the liver was higher in the IV compared to IP (P < 0.001) and SC (P < 0.05). CONCLUSION: We demonstrate that the Raji cell line inoculation route could determine the xenograft model system behavior in terms of survival, tumor burden, and dissemination pattern and gives the model the specific features suitable for testing the specific hypothesis in CAR T cell therapy. We also conclude outcome measures for CAR T cell studies that do not require imaging techniques.


Subject(s)
Antigens, CD19/immunology , Immunotherapy, Adoptive/methods , Lymphoma, Non-Hodgkin/therapy , Receptors, Chimeric Antigen , Xenograft Model Antitumor Assays/methods , Animals , Body Weight , Cell Line, Tumor , Disease Models, Animal , Female , Lymphoma, Non-Hodgkin/mortality , Lymphoma, Non-Hodgkin/pathology , Male , Mice , Mice, Inbred NOD , Neoplasm Invasiveness , Random Allocation , T-Lymphocytes/immunology
3.
Article in English | MEDLINE | ID: mdl-27229858

ABSTRACT

Breast cancer is a heterogeneous disease, and among all types, triple-negative breast cancer (TNBC) is characterised by high risk of recurrence. The discovery of microRNAs (miRNA) has opened the door for targeted therapy of TNBC. miR-340 down-regulation and sub-G1-accumulated cells in flowcytometry were observed in metastatic TNBC cells (data in publication), leading us to investigate the potential tumour suppressive role of this miRNA on cell-cycle-related genes. A lentiviral vector containing miR-340 was applied to over-express miR-340 in TNBC cell line, MDA-MB-231. Then, the expression of some cell-cycle-regulating genes including cyclin A2 (cyclin A2), Cyclin-dependent kinases 2 (CDK2), cyclin-dependent kinase inhibitors (P16, P18 and P27), Retinoblastoma (RB) and transcription factors (SMAD 4, SOX2 and SOX17) was investigated using quantitative RT-PCR. The results showed a decline in the expression of SOX2, P16 and P27 after miR-340 over-expression, whereas we observed an increase in the expression of cyclin A2, CDK2, SOX17, P18, SMAD 4 and RB. The over-expression of tumour suppressor genes such as RB and SOX17 and down-regulation of an oncogene such as SOX2 were in accordance to the inhibitory role of miR-340 that causes blockage of breast cancer metastasis which should be further investigated.


Subject(s)
Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Triple Negative Breast Neoplasms/genetics , Cell Cycle/genetics , Cell Line, Tumor , Cyclin A2/genetics , Cyclin-Dependent Kinase 2/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p18/genetics , Cyclin-Dependent Kinase Inhibitor p27/genetics , Genetic Vectors , Humans , Lentivirus , Neoplasm Metastasis , Retinoblastoma Protein/genetics , SOXB1 Transcription Factors/genetics , SOXF Transcription Factors/genetics , Smad4 Protein/genetics , Triple Negative Breast Neoplasms/pathology
4.
Arch Iran Med ; 19(6): 420-5, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27293058

ABSTRACT

PURPOSE: Human Piwil2, a member of Piwi subfamily of Argonaute proteins, is primarily expressed in testis, where it regulates self-renewal of germ cells. However, its ectopic expression has been reported with several tumors, including breast cancer. The upregulation of piwil2 in various stages of breast cancer suggested its suitability as a novel tumor biomarker. Considering the vital role of microRNAs (miRNAs) in regulating the expression of most human genes, we hypothesized a concomitant downregulation of the bioinformatically-predicted piwil2-targetting microRNAs in breast cancer.  METHOD: We employed different bioinformatic tools to predict piwil2-targeting miRNAs. Then, from the list of predicted miRNAs, we chose two less studied miRNAs (miR-1267 and miR-2276) for experimental validation. Using a real-time RT-PCR approach, we quantified the relative expression of the miRNAs in 31 pairs of formalin-fixed paraffin-embedded tumor/non-tumor tissue samples. RESULTS: Our data revealed a noticeable but not statistically significant (P = 0.133) downregulation of miR-1267 in tumor samples, compared to non-tumor samples obtained from the same patients. Downregulation of miR-1267 was more significant in higher grades of malignancies (fold change = 2.39, P = 0.033) and also in lymph nodes containing high-grade tumor cells (fold change = 6.66, P = 0.02).  Interestingly, a significant upregulation of miR-1267 was observed in tumors at high stages (stage 3a, 3b), compared to low stages (stage 2a, 2b) (fold change = 8.05, P = 0.048). Similar patterns of expression alteration were also observed for miR-2276. CONCLUSION: Altogether, our findings suggest a probable tumor suppressor role for miR-1267 and miR-2276 in breast tumor initiation and progression, but a probable promoting role for them in invasion and metastasis.


Subject(s)
Argonaute Proteins/genetics , Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Adult , Aged , Cell Line, Tumor , Computational Biology , Down-Regulation , Female , Humans , Iran , Middle Aged , Real-Time Polymerase Chain Reaction
5.
Parasite Immunol ; 35(12): 397-408, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23710803

ABSTRACT

The use of an appropriate delivery system has recently emerged as a promising approach for the development of effective vaccination against visceral leishmaniasis (VL). Here, we compare two vaccine delivery systems, namely electroporation and cationic solid-lipid nanoparticle (cSLN) formulation, to administer a DNA vaccine harbouring the L. donovani A2 antigen along with L. infantum cysteine proteinases [CPA and CPB without its unusual C-terminal extension (CPB(-CTE) )] and evaluate their potential against L. infantum challenge. Prime-boost administration of the pcDNA-A2-CPA-CPB(-CTE) delivered by either electroporation or cSLN formulation protects BALB/c mice against L. infantum challenge and that protective immunity is associated with high levels of IFN-γ and lower levels of IL-10 production, leading to a strong Th1 immune response. At all time points, the ratio of IFN-γ: IL-10 induced upon restimulation with rA2-rCPA-rCPB and F/T antigens was significantly higher in vaccinated animals. Moreover, Th2-efficient protection was elicited through a high humoral immune response. Nitric oxide production, parasite burden and histopathological analysis were also in concordance with other findings. Overall, these data indicate that similar to the electroporation delivery system, cSLNs as a nanoscale vehicle of Leishmania antigens could improve immune response, hence indicating the promise of these strategies against visceral leishmaniasis.


Subject(s)
Electroporation , Leishmaniasis Vaccines/administration & dosage , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/prevention & control , Nanoparticles , Vaccines, DNA/administration & dosage , Animals , Antibodies, Protozoan/blood , Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , Cysteine Proteases/genetics , Cysteine Proteases/immunology , Female , Immunity, Humoral , Immunization, Secondary , Immunoglobulin G/blood , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Leishmania donovani/immunology , Leishmania donovani/physiology , Leishmania infantum/immunology , Leishmaniasis Vaccines/immunology , Leishmaniasis, Visceral/parasitology , Lipids/immunology , Mice , Mice, Inbred BALB C , Parasite Load , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Vaccination , Vaccines, DNA/immunology
6.
Middle East J Dig Dis ; 3(1): 20-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-25197528

ABSTRACT

BACKGROUND Gastric dysplasia (GD) is a precursor lesion of gastric adenocarcinoma. Intestinal type gastric carcinoma commonly shows microsatellite instability (MSI) and the diffuse type is associated with down regulation of E-cadherin. HER-2/neu is over-expressed in some cases of gastric cancer. In this study, MSI and expression rates of HER-2/neu and E-cadherin in GD were evaluated. METHODS Paraffin blocks of 21 cases of low grade dysplasia (LD), 11 cases of high grade dysplasia (HD) and 25 cases of indefinite for dysplasia (ID) were collected. After deparaffinization and antigen retrieval, the sections were incubated with antibodies against E-cadherin, hMLH1, hMSH2 and HER-2/neu. The streptavidin-biotin complex method was used followed by peroxidase enzyme development with diaminobenzidine. RESULTS HER-2/neu was positive in six cases of HD (50%), four LD (21%) and two ID (9%). E-cadherin was absent in two cases of LD and showed normal expression in all HD and ID cases. hMLH1 expression was absent or markedly decreased only in the zones of dysplasia in HD (3/11), LD (3/21) and ID (4/25). Absence or diminished expression of hMSH2 was seen in HD (3/11), LD (2/21) and ID (3/25) cases. HER-2/neu expression showed close association with diminished expression of hMLH1 or hMSH2 (p < 0.05). CONCLUSION Stepwise increase in the expression rate of HER-2/neu was seen in ID, LD and HD cases implying its role in cancer evolution. The absence of hMLH1 and hMSH2 in GD may predispose individuals to over-expression of other oncogenes such as HER-2/neu. Abnormal expression of E-cadherin is not a frequent finding in GD.

7.
J Biomed Inform ; 44(2): 216-20, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21078409

ABSTRACT

The interests in journal impact factor (JIF) in scientific communities have grown over the last decades. The JIFs are used to evaluate journals quality and the papers published therein. JIF is a discipline specific measure and the comparison between the JIF dedicated to different disciplines is inadequate, unless a normalization process is performed. In this study, normalized impact factor (NIF) was introduced as a relatively simple method enabling the JIFs to be used when evaluating the quality of journals and research works in different disciplines. The NIF index was established based on the multiplication of JIF by a constant factor. The constants were calculated for all 54 disciplines of biomedical field during 2005, 2006, 2007, 2008 and 2009 years. Also, ranking of 393 journals in different biomedical disciplines according to the NIF and JIF were compared to illustrate how the NIF index can be used for the evaluation of publications in different disciplines. The findings prove that the use of the NIF enhances the equality in assessing the quality of research works produced by researchers who work in different disciplines.


Subject(s)
Journal Impact Factor , Periodicals as Topic/standards , Bibliometrics , Databases, Bibliographic , Publishing
8.
Eur J Cancer Care (Engl) ; 15(5): 497-500, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17177910

ABSTRACT

Although it is quite rare, second primary neoplasms in cancer patients may present with the signs and symptoms of malignant spinal cord compression. Primary spinal cord tumours in the cancer patients may be deceptive and considered as the recurrent first cancer. Therefore, it should be precisely differentiated and appropriately managed. We report such a case of intramedullary ependymoma of the cervical spinal cord mimicking metatstatic recurrent lymphoma and causing cord compression. A 50-year-old man developed intramedullary ependymoma of the cervical spinal cord 1.5 years following chemoradiation for Waldeyer's ring lymphoma. He presented with a 2-month history of neck pain, progressive upper- and lower-extremity numbness and weakness, and bowel and bladder dysfunction. Magnetic resonance imaging revealed an intramedullary expansive lesion extending from C4 to C6 levels of the cervical spinal cord. The clinical and radiological findings were suggestive of malignant process. A comprehensive investigation failed to detect another site of disease. He underwent operation, and the tumour was subtotally resected. The patient's neurological deficits improved subsequently. The development of the intramedullary ependymoma following treating lymphoma has not been reported. We describe the clinical, radiological and pathological findings of this case and review the literature.


Subject(s)
Ependymoma/diagnosis , Neoplasms, Second Primary/diagnosis , Spinal Cord Compression/etiology , Spinal Cord Neoplasms/diagnosis , Cervical Vertebrae , Diagnosis, Differential , Ependymoma/drug therapy , Ependymoma/radiotherapy , Humans , Lymphoma, Non-Hodgkin/drug therapy , Lymphoma, Non-Hodgkin/radiotherapy , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Oropharyngeal Neoplasms/drug therapy , Oropharyngeal Neoplasms/radiotherapy , Quadriplegia/etiology
9.
Br J Cancer ; 94(1): 128-35, 2006 Jan 16.
Article in English | MEDLINE | ID: mdl-16404366

ABSTRACT

Epithelial cell adhesion molecule (Ep-CAM; CD326) is used as a target by many immunotherapeutic approaches, but little data are available about Ep-CAM expression in major human malignancies with respect to level, frequency, tumour stage, grade, histologic tumour type and impact on survival. We analysed by immunohistochemical staining tissue microarrays with 4046 primary human carcinoma samples from colon, stomach, prostate and lung cancers for both frequency and intensity of Ep-CAM expression under highly standardised conditions. A total of 3360 samples were analysable. High-level Ep-CAM expression was observed in 97.7% (n=1186) of colon, 90.7% of gastric (n=473), and 87.2% of prostate cancers (n=414), and in 63.9% of lung cancers (n=1287). No detectable Ep-CAM staining was found with only 0.4% of colon, 2.5% of gastric, 1.9% of prostate cancers, and 13.5% of lung cancers. The only significant correlation of Ep-CAM expression with tumour grading was observed in colon cancer where high-level Ep-CAM expression on grade 3 tumours was down to 92.1% (P<0.0001). Adenosquamous and squamous carcinomas of the lung had a lower percentage of high-level Ep-CAM expression compared to adenocarcinomas with 35.4 and 53.6%, respectively, and with 45.5 and 17.3% of tumours being Ep-CAM negative. With the exception of moderately differentiated colon carcinoma, where patients not expressing Ep-CAM on their tumours showed an inferior survival (P=0.0014), correlation of Ep-CAM expression with survival did not reach statistical significance for any of the other cancer indications and subgroups. In conclusion, the data strongly support the notion that Ep-CAM is a prime target for immunotherapies in major human malignancies. This is because the most common human cancers show (i) a low frequency of Ep-CAM-negative tumours, (ii) a high frequency of Ep-CAM expression on cells of a given tumour, and (iii) for most cancers, an insignificant influence of tumour staging, grading and histology on Ep-CAM expression.


Subject(s)
Antigens, Neoplasm/biosynthesis , Cell Adhesion Molecules/biosynthesis , Colonic Neoplasms/genetics , Lung Neoplasms/genetics , Neoplasm Staging , Prostatic Neoplasms/genetics , Stomach Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Antigens, Neoplasm/physiology , Biomarkers, Tumor , Cell Adhesion Molecules/physiology , Colonic Neoplasms/pathology , Epithelial Cell Adhesion Molecule , Female , Gene Expression Profiling , Humans , Immunohistochemistry , Immunotherapy , Lung Neoplasms/pathology , Male , Middle Aged , Prognosis , Prostatic Neoplasms/pathology , Protein Array Analysis , Retrospective Studies , Stomach Neoplasms/pathology , Survival Analysis
10.
Brain Res ; 1020(1-2): 30-6, 2004 Sep 10.
Article in English | MEDLINE | ID: mdl-15312784

ABSTRACT

Adrenomedullin (AM) immunoreactivity and mRNA, in addition to a large number of specific AM-binding sites, exist in the rat spinal cord. However, no phenotype has been reported for AM in the spinal cord. Here, expression of c-fos in response to intrathecal (i.t.) administration of AM, proadrenomedullin N-terminal 20 peptide (PAMP) and calcitonin gene-related peptide (CGRP) was examined in the thoracic, lumbar and sacral regions of spinal cord in conscious rats. Two hours after i.t. administration of either CGRP (2.5 and 10 microg) or AM (10 microg), the number of c-Fos immunoreactive nuclei was increased in all the spinal regions examined in this study, with the highest increase observed in the superficial dorsal horn. Few cells with c-fos immunoreactivity were found in the spinal cord of rats 2 h after i.t. injection of either saline or PAMP. Effects of AM (10 microg) and CGRP (2.5 microg) on c-fos expression were blocked when rats were pretreated with 40 microg of intrathecal CGRP8-37 (CGRP1 receptor antagonist). Fos-like immunoreactivity induced by i.t. CGRP and/or AM were also significantly abolished by i.t. administration of the nitric oxide (NO) inhibitor, l-NAME, indicating that endogenous NO is a necessary intermediary in CGRP and AM induced c-fos expression in the rat spinal cord. In conclusion, AM induces c-fos expression in rat spinal cord when administered intrathecally, with the pattern being similar to those produced by i.t. CGRP. Effects of the two peptides are sensitive to CGRP8-37 and l-NAME.


Subject(s)
Calcitonin Gene-Related Peptide/physiology , Nitric Oxide/metabolism , Peptides/physiology , Proto-Oncogene Proteins c-fos/metabolism , Spinal Cord/metabolism , Adrenomedullin , Analysis of Variance , Animals , Calcitonin Gene-Related Peptide/administration & dosage , Dose-Response Relationship, Drug , Enzyme Inhibitors/administration & dosage , Injections, Spinal , Male , NG-Nitroarginine Methyl Ester/administration & dosage , Neurons/drug effects , Neurons/metabolism , Peptides/administration & dosage , Rats , Rats, Sprague-Dawley , Spinal Cord/cytology , Spinal Cord/drug effects
12.
Hepatogastroenterology ; 48(39): 609-13, 2001.
Article in English | MEDLINE | ID: mdl-11462886

ABSTRACT

BACKGROUND/AIMS: Appendectomy for suspected appendicitis cases is a common procedure. Its clinical diagnosis needs to be supported by accurate confirmatory tests. No single paraclinical test with a high degree of sensitivity and specificity is available for its diagnosis. The appendix contains numerous serotonin-producing cells (enterochromaffin cells). In the inflammatory process and subsequent cell injury, serotonin is released and converted to 5-HIAA (5-hydroxy indole acetic acid). We studied the elevation of 5-HIAA in the spot urine of acute appendicitis patients. METHODOLOGY: 5-HIAA was measured by high-performance liquid chromatography in the spot urine samples of 40 healthy individuals and 166 patients who presented to emergency units of the university hospitals with acute abdominal pain. The results of the urine concentrations were compared to the histopathology reports of the removed appendices and the final diagnosis of other diseases. RESULTS: From 80 cases with a presumptive diagnosis of appendicitis, 73 were operated on and seven cases discharged after a few hours observation. Sixty-five out of 66 documented appendicitis patients showed a striking increase of urinary spot 5-HIAA with significant differences vs. all cases of healthy control individuals (P < 0.001). The 5-HIAA values of all of the negative appendectomy cases (n = 7) and all of the discharged cases after the observation period (n = 7) were within healthy control ranges. The mean value of the appendicitis group (42.76 +/- 2.26 mumol/L) was also significantly higher vs. all other acute abdomens which could mimic acute appendicitis (P < 0.05) excepting gastroenteritis patients. Considering 20 mumol/L as the cutoff value sensitivity, specificity, positive and negative predictive values of this test for discriminating appendicitis in clinically suspected patients were 98%, 100%, 100% and 93%, respectively and in all acute abdomens were 98%, 71%, 69% and 98.6%, respectively. The patients with gastroenteritis also showed elevation of 5-HIAA (43.05 +/- 2.7 mumol/L) vs. other nonappendicitis groups (P < 0.05). CONCLUSIONS: We have concluded that measurement of 5-HIAA in spot urine is a highly reliable test supporting the clinical diagnosis of appendicitis and if it does not show an increase, appendicitis can be ruled out with a very high degree of confidence which helps to reduce unnecessary appendectomies. In clinically suspected appendicitis patients with diarrhea, an increase of 5-HIAA may not confirm the diagnosis.


Subject(s)
Appendicitis/diagnosis , Hydroxyindoleacetic Acid/urine , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Appendicitis/urine , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Infant , Male , Middle Aged , Predictive Value of Tests , Reference Values
13.
Cancer Lett ; 169(1): 69-75, 2001 Aug 10.
Article in English | MEDLINE | ID: mdl-11410327

ABSTRACT

Genetic alterations in the p53 tumor suppressor gene with or without protein overexpression have been reported to be associated with sporadic breast cancer. To assess the role of p53 in infiltrative ductal breast carcinoma among Iranian patients, p53 protein expression and p53 gene mutations were studied by immunohistochemical analysis and single-strand conformation polymorphism, respectively. The p53 protein was expressed in 25 out of 51 (49%) tumors and p53 gene mutations were detected in 17 out of 37 (46%) tested tumors. No significant correlation was observed between p53 gene mutations and p53 protein expression. There was no significant correlation between p53 abnormalities (mutation and expression) and tumor size, histological grade, nodal status, and progesterone receptor expression. However, a non-statistically significant trend of association (P=0.07) was observed between p53 gene mutations and lack of estrogen receptor. The high percentage of alterations both in p53 gene and protein among southern Iranian breast cancer patients suggests that p53 is probably one of the genes involved in sporadic breast cancer in this area.


Subject(s)
Breast Neoplasms/genetics , Carcinoma, Ductal, Breast/genetics , Genes, p53/genetics , Tumor Suppressor Protein p53/biosynthesis , Adult , Aged , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/metabolism , Carcinoma, Ductal, Breast/pathology , Female , Gene Expression , Humans , Immunohistochemistry , Middle Aged , Mutation , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Receptors, Estrogen/biosynthesis , Receptors, Progesterone/biosynthesis , Tumor Suppressor Protein p53/genetics
14.
Pathol Oncol Res ; 7(1): 39-41, 2001.
Article in English | MEDLINE | ID: mdl-11349219

ABSTRACT

Breast cancer is considered a major malignancy among women worldwide. The contribution of genetic elements to the onset of familial breast cancer has already been established. The current study investigate the alfele frequency of HLA-DRB 1 in 36 primary operable female breast cancer patients from southern Iran by polymerase chain reaction using sequence specific primers (PCR-SSP). Results were compared with those of 36 female control subjects. Statistical analysis was performed and P values were determined for each character. Our results indicated that the frequency of HLA-DRB 1*12 allele is significantly higher in the patient group (p<0.03) compared to the control group. In addition, HLA-DRB1*11 appeared to be as the most frequent allele in the control group (29.2%) and had approximately the same distribution among the patient group (22.5%).


Subject(s)
Alleles , Breast Neoplasms/genetics , Genetic Predisposition to Disease , HLA-DR Antigens/genetics , Adult , Breast Neoplasms/ethnology , DNA, Neoplasm/analysis , DNA, Neoplasm/metabolism , Female , HLA-DRB1 Chains , Humans , Iran/epidemiology , Polymerase Chain Reaction , Risk Factors
15.
J Immunol ; 165(5): 2628-36, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10946291

ABSTRACT

The possible immunomodulatory role of polymorphonuclear leukocytes (PMN) in CD4+ T lymphocyte differentiation in mice was examined by studying the effect of transient depletion of PMN during the early phase after Leishmania major delivery. A single injection of the PMN-depleting NIMP-R14 mAb 6 h before infection with L. major prevented the early burst of IL-4 mRNA transcription otherwise occurring in the draining lymph node of susceptible BALB/c mice. Since this early burst of IL-4 mRNA transcripts had previously been shown to instruct Th2 differentiation in mice from this strain, we examined the effect of PMN depletion on Th subset differentiation at later time points after infection. The transient depletion of PMN in BALB/c mice was sufficient to inhibit Th2 cell development otherwise occurring after L. major infection. Decreased Th2 responses were paralleled with partial resolution of the footpad lesions induced by L. major. Furthermore, draining lymph node-derived CD4+ T cells from PMN-depleted mice remained responsive to IL-12 after L. major infection, unlike those of infected BALB/c mice receiving control Ab. PMN depletion had no effect when the NIMP-R14 mAb was injected 24 h postinfection. The protective effect of PMN depletion was shown to be IL-12 dependent, as concomitant neutralization of IL-12 reversed the protective effect of PMN depletion. These results suggest a role for an early wave of PMN in the development of the Th2 response characteristic of mice susceptible to infection with L. major.


Subject(s)
Leishmania major/immunology , Leishmaniasis, Cutaneous/immunology , Neutrophils/immunology , Th2 Cells/metabolism , Animals , Antibodies, Monoclonal/administration & dosage , Cell Differentiation/immunology , Cell Movement/immunology , Cytokines/biosynthesis , Cytokines/genetics , Disease Susceptibility , Immunity, Cellular , Immunity, Innate , Injections, Intraperitoneal , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/immunology , Interleukin-12/antagonists & inhibitors , Interleukin-12/immunology , Interleukin-12/physiology , Leishmaniasis, Cutaneous/pathology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymph Nodes/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Neutropenia/immunology , Neutropenia/pathology , Neutrophils/parasitology , Neutrophils/pathology , RNA, Messenger/biosynthesis , Th2 Cells/immunology , Th2 Cells/parasitology , Th2 Cells/pathology , Time Factors
16.
Acta Cytol ; 43(5): 767-70, 1999.
Article in English | MEDLINE | ID: mdl-10518128

ABSTRACT

OBJECTIVE: To study the cytologic findings of papillary breast carcinoma by fine needle aspiration. STUDY DESIGN: The study group consisted of fine needle aspiration (FNA) specimens of breast tumors from nine patients performed during the period 1988-1997. Eight were female, and one was male. The FNA results were compared with the final histologic diagnosis. RESULTS: The tumor sizes were 4-6.5 cm. The aspirations yielded a good amount of bloody material. The smears revealed high cellularity, papillary clusters, isolated low-to-tall columnar cells, mild to moderate atypia, hemorrhagic background, foam and hemosiderin-laden macrophages, calcification, rare mitoses, palisading row of cells and bipolar cytoplasmic eosinophilic granules. The smears were diagnosed as either suspicious or suggestive of papillary carcinoma. The histologic examination revealed invasive papillary carcinoma. CONCLUSION: Papillary carcinoma of the breast can be diagnosed by using a panel of cytologic findings that includes hypercellularity, papillary clusters, hemorrhagic background, palisading rows of tall columnar cells, cellular atypia and calcification. The interesting finding in this study was the presence of eosinophilic bipolar cytoplasmic granules, which has not been reported before.


Subject(s)
Breast Neoplasms, Male/pathology , Breast Neoplasms/pathology , Carcinoma, Papillary/pathology , Aged , Biopsy, Needle/methods , Breast Neoplasms/surgery , Breast Neoplasms, Male/surgery , Carcinoma, Papillary/surgery , Female , Humans , Male , Mastectomy, Segmental , Middle Aged
17.
APMIS ; 107(7): 681-4, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10440065

ABSTRACT

Fungal colonization was observed in the duodenal biopsy specimens of a nine-year-old girl who complained of anorexia and epigastric pain. Endoscopy revealed gastric redness and Geotrichum candidum was identified in the duodenum by histopathology and tissue culture. Immunologic work-up showed low serum levels of IgA and IgM. She was treated with ranitidine and antacids for gastritis. At follow-up, the levels of immunoglobulins had normalized, no fungal elements were detected, and clinical symptoms had disappeared. Duodenal invasion by G. candidum has not been described so far. Duodenal colonization by G. candidum may occur when mucosal immunity is disturbed and may be the source of dissemination in severe immunodeficiency states.


Subject(s)
Duodenitis/immunology , Duodenum/immunology , Geotrichosis/immunology , Geotrichum/immunology , Child, Preschool , Duodenitis/drug therapy , Duodenitis/microbiology , Duodenitis/pathology , Duodenum/microbiology , Duodenum/pathology , Female , Follow-Up Studies , Geotrichosis/drug therapy , Geotrichosis/microbiology , Geotrichosis/pathology , Geotrichum/isolation & purification , Humans , Immunoglobulin A/immunology , Immunoglobulin M/immunology
18.
Acta Cytol ; 43(2): 139-42, 1999.
Article in English | MEDLINE | ID: mdl-10097700

ABSTRACT

OBJECTIVE: To study the cytologic findings of follicular variant of papillary thyroid carcinoma (FVPTC) and to compare them with the cytologic findings on other thyroid lesions. STUDY DESIGN: The study group consisted of aspirate smears from 15 cases of histologically proven FVPTC. The control group consisted of 152 cases, including adenomatous colloid goiter (70), usual papillary carcinoma (40), follicular adenoma (30), Hürthle cell neoplasm (7) and medullary carcinoma (5). RESULTS: The smears of FVPTC revealed numerous colloid balls in the background, multilayered microfollicles (rosettes), numerous nuclear grooves and inclusions in the monolayer sheets of follicular cells, very rare giant cells, absence of calcification and papillary clusters. Rosettelike microfollicles and numerous colloid balls were not seen in the control group. CONCLUSION: The combination of numerous colloid balls and rosettelike microfollicles was frequently seen in FVPTC. This combination was not observed in the control group.


Subject(s)
Carcinoma, Papillary, Follicular/diagnosis , Carcinoma, Papillary, Follicular/pathology , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/pathology , Adenoma/diagnosis , Adenoma/pathology , Adult , Biopsy, Needle , Diagnosis, Differential , Female , Goiter/diagnosis , Goiter/pathology , Humans , Inclusion Bodies/pathology , Male , Middle Aged
19.
Acta Cytol ; 42(6): 1437-40, 1998.
Article in English | MEDLINE | ID: mdl-9850656

ABSTRACT

BACKGROUND: Papillary Hürthle cell carcinoma with lymphoplasmacytic stroma is a newly recognized variant of papillary carcinoma of the thyroid gland. Fine needle aspiration findings reveal some points that have not been reported previously. CASE: A 50-year-old female presented with a left lobe thyroid mass. Fine needle aspiration of the nodule yielded cellular smears, mostly in large and small papillary clusters of Hürthle cells, with nuclear grooves and rare nuclear inclusions in a lymphoplasmacytic background. Isolated Hürthle cell and multinucleated giant cells were also seen. Histopathologic examination of the 3-cm-diameter nodule showed papillary Hürthle cell carcinoma with lymphocytic stroma, or "Warthin-like tumor" of the thyroid, with capsular invasion. CONCLUSION: The presence of papillary clusters with nuclear features of papillary carcinoma and oxyphilic cytoplasm in a lymphoplasmacytic background should raise the diagnosis of Warthin-like tumor of the thyroid.


Subject(s)
Adenolymphoma/pathology , Carcinoma, Papillary/pathology , Thyroid Neoplasms/pathology , Adenoma, Oxyphilic/pathology , Biopsy, Needle , Female , Humans , Inclusion Bodies/pathology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...